BRSYF (BrainsWay) FFO


BRSYF BrainsWay Ltd BRSYF
70 GF Score
Price $13.55
GF Value $6.71
! 3 Warning Signs
View Full Analysis

What is BrainsWay FFO?

FFO (Funds from operations) only applies to REITs.

BRSYF
70GF Score
BrainsWay Ltd BRSYF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BrainsWay (BRSYF) Overvalued in 2026?

Based on GuruFocus' analysis, BrainsWay stock appears to be overvalued. The current stock price of $13.55 is trading 101.9% above its estimated GF Value™ of $6.71.

Key valuation signals for BRSYF:

  • FFO:
  • GF Value™: $6.71 vs. price of $13.55 (101.9% above fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the BRSYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BrainsWay Business Description

Other Exchanges BWAY:USABWAY:Israel
Address 16 Hartum Street, 14th Floor, RAD Tower, Har HaHotzvim, Jerusalem, ISR, 9777516
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
70GF Score

Get the complete analysis for BRSYF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.55
Price
$6.71
GF Value